Caxton Associates (New York)’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,619
| Closed | -$463K | – | 468 |
|
|
2023
Q3 | $463K | Buy |
7,619
+4,973
| +188% | +$302K | 0.06% | 254 |
|
|
2023
Q2 | $174K | Buy |
+2,646
| New | +$174K | 0.03% | 424 |
|
|
2023
Q1 | – | Sell |
-3,382
| Closed | -$468K | – | 497 |
|
|
2022
Q4 | $468K | Hold |
3,382
| – | – | 0.03% | 234 |
|
|
2022
Q3 | $428K | Sell |
3,382
-7,626
| -69% | -$965K | 0.06% | 255 |
|
|
2022
Q2 | $911K | Buy |
11,008
+9,339
| +560% | +$773K | 0.09% | 129 |
|
|
2022
Q1 | $162K | Sell |
1,669
-2,922
| -64% | -$284K | 0.01% | 431 |
|
|
2021
Q4 | $917K | Buy |
+4,591
| New | +$917K | 0.09% | 110 |
|